These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

189 related items for PubMed ID: 35862943

  • 1. Activity of Delafloxacin and Levofloxacin against Stenotrophomonas maltophilia at Simulated Plasma and Intrapulmonary pH Values.
    Vialichka A, Biagi M, Meyer K, Wu T, Shajee A, Tan X, Wenzler E.
    Microbiol Spectr; 2022 Aug 31; 10(4):e0270521. PubMed ID: 35862943
    [Abstract] [Full Text] [Related]

  • 2. Activity of Potential Alternative Treatment Agents for Stenotrophomonas maltophilia Isolates Nonsusceptible to Levofloxacin and/or Trimethoprim-Sulfamethoxazole.
    Biagi M, Tan X, Wu T, Jurkovic M, Vialichka A, Meyer K, Mendes RE, Wenzler E.
    J Clin Microbiol; 2020 Jan 28; 58(2):. PubMed ID: 31748318
    [Abstract] [Full Text] [Related]

  • 3. In Vitro Time-Kill Studies of Trimethoprim/Sulfamethoxazole against Stenotrophomonas maltophilia versus Escherichia coli Using Cation-Adjusted Mueller-Hinton Broth and ISO-Sensitest Broth.
    Lasko MJ, Gethers ML, Tabor-Rennie JL, Nicolau DP, Kuti JL.
    Antimicrob Agents Chemother; 2022 Mar 15; 66(3):e0216721. PubMed ID: 35007135
    [Abstract] [Full Text] [Related]

  • 4. Levofloxacin Efflux and smeD in Clinical Isolates of Stenotrophomonas maltophilia.
    Chong SY, Lee K, Chung HS, Hong SG, Suh Y, Chong Y.
    Microb Drug Resist; 2017 Mar 15; 23(2):163-168. PubMed ID: 27294684
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Activity of delafloxacin versus that of levofloxacin against anaerobic and microaerophilic isolates.
    Boyanova L, Yordanov D, Ouzounova-Raykova V, Markovska R, Marteva-Proevska Y, Mitov I.
    Anaerobe; 2020 Apr 15; 62():102150. PubMed ID: 31987991
    [Abstract] [Full Text] [Related]

  • 9. In Vitro Activity of Delafloxacin and Microbiological Response against Fluoroquinolone-Susceptible and Nonsusceptible Staphylococcus aureus Isolates from Two Phase 3 Studies of Acute Bacterial Skin and Skin Structure Infections.
    McCurdy S, Lawrence L, Quintas M, Woosley L, Flamm R, Tseng C, Cammarata S.
    Antimicrob Agents Chemother; 2017 Sep 15; 61(9):. PubMed ID: 28630189
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.